Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.08 USD | +1.07% | +9.59% | -15.68% |
Financials (USD)
Sales 2024 * | 293M | Sales 2025 * | 354M | Capitalization | 1.8B |
---|---|---|---|---|---|
Net income 2024 * | -180M | Net income 2025 * | -159M | EV / Sales 2024 * | 5.54 x |
Net cash position 2024 * | 173M | Net cash position 2025 * | 139M | EV / Sales 2025 * | 4.69 x |
P/E ratio 2024 * |
-10.1
x | P/E ratio 2025 * |
-11.8
x | Employees | 919 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.22% |
Latest transcript on Twist Bioscience Corporation
1 day | +1.07% | ||
1 week | +9.59% | ||
Current month | -9.41% | ||
1 month | -9.20% | ||
3 months | -4.13% | ||
6 months | +102.87% | ||
Current year | -15.68% |
Managers | Title | Age | Since |
---|---|---|---|
William Banyai
FOU | Founder | 69 | 13-02-03 |
Emily Leproust
CEO | Chief Executive Officer | 50 | 13-03-31 |
Adam Laponis
DFI | Director of Finance/CFO | 47 | Jan. 04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Ragusa
BRD | Director/Board Member | 64 | 16-10-31 |
Jan Johannessen
BRD | Director/Board Member | 67 | 18-09-30 |
Keith Crandell
BRD | Director/Board Member | 63 | 13-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.68% | 1 M€ | 0.00% | - | |
1.87% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 31.08 | +1.07% | 1,234,632 |
24-04-24 | 30.75 | -2.38% | 1,402,387 |
24-04-23 | 31.5 | +6.96% | 1,065,616 |
24-04-22 | 29.45 | +5.37% | 935,699 |
24-04-19 | 27.95 | -1.45% | 1,089,838 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.68% | 1.8B | |
-4.66% | 87.53B | |
+2.63% | 40.42B | |
-21.76% | 29.48B | |
+55.64% | 25.43B | |
-14.78% | 15.59B | |
-18.49% | 11.49B | |
-15.61% | 11.1B | |
-44.02% | 11.3B | |
+4.64% | 8.75B |
- Stock Market
- Equities
- TWST Stock